Atopic dermatitis (eczema): open trials in Germany

30 open trials have a site in Germany. Registry data; only the trial team decides who can take part.

NCT07444801
Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact
Research · University Hospital Schleswig-Holstein
Department of Dermatology of the University Hospital Augsburg, Augsburg · CCIM, Institut für Entzündungsmedizin UKSH Lübeck, Lübeck
Registry updated 2026-03-03
NCT03358693
Molecular Signatures in Inflammatory Skin Disease
Research · Prof. Dr. Stephan Weidinger
Department of Dermatology, University Hospital Schleswig Holstein, Campus Kiel, Kiel
Registry updated 2025-07-22
NCT03361215
Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis
Research · University Hospital Schleswig-Holstein
Department of Dermatology, University Hospital Schleswig Holstein, Campus Kiel, Kiel
Registry updated 2025-07-22
NCT05694884
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated with Dupilumab.
Trial Treatment · Phase 2 · Aslan Pharmaceuticals Pte Ltd
Charite Universitaetsmedizin Berlin KöR, Berlin · Elbe Kliniken Stade-Buxtehude Elbe Klinikum Buxtehude gGmbH, Buxtehude · TFS Trial Form Support GmbH, Hamburg
Registry updated 2024-05-31
NCT03057860
TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic Dermatitis
Research · Technische Universität Dresden
Department of Dermatology, UniversityAllergyCenter, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden · Clinics for Dermatology, Allergy and Venerology, Hannover Medical School, Hanover · Head Centre for Inflammatory Skin Diseases, Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel
Registry updated 2022-05-09

All Atopic dermatitis (eczema) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

Atopic dermatitis (eczema): open trials in Germany

Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact

Molecular Signatures in Inflammatory Skin Disease

Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated with Dupilumab.

TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic Dermatitis